Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/10/25 → 07/31/27 |
Funding
- IQVIA Incorporated: $183,699.00
ONO-2020-02: A Phase II, 26-week, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in patients with mild to moderate Alzheimer¿s Disease
- Szigeti, Kinga (PI)
Project: Research